Report

1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 30
1.3.2 INCLUSIONS AND EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 31
1.4 CURRENCY CONSIDERED 31
1.5 STAKEHOLDERS 32
1.6 SUMMARY OF CHANGES 32
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
2.1.1 SECONDARY DATA 34
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 38
2.1.2.2 Key industry insights 39
2.2 MARKET SIZE ESTIMATION 40
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS) 40
2.2.2 TOP-DOWN APPROACH 41
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS 41
2.2.4 DEMAND-SIDE ANALYSIS 41
2.3 GROWTH FORECAST 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 44
2.5 MARKET SHARE ANALYSIS 45
2.6 RESEARCH ASSUMPTIONS 45
2.7 RISK ASSESSMENT 45
2.8 RESEARCH LIMITATIONS 46
3 EXECUTIVE SUMMARY 47
4 PREMIUM INSIGHTS 51
4.1 STRUCTURAL HEART DEVICES MARKET OVERVIEW 51
4.2 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT AND COUNTRY 52
4.3 STRUCTURAL HEART DEVICES MARKET, BY COUNTRY 53
?
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
5.2.1.1 Growing geriatric population 55
5.2.1.2 Increasing preference for minimally invasive surgeries 56
5.2.1.3 Rising awareness about structural heart diseases 56
5.2.2 RESTRAINTS 58
5.2.2.1 High cost of devices and limited reimbursement 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Emergence of tissue-engineered heart valves 58
5.2.3.2 Expanding healthcare facilities in emerging economies 59
5.2.4 CHALLENGES 60
5.2.4.1 Regulatory and approval challenges 60
5.2.4.2 Intense competition among market players 61
5.2.4.3 Lack of skilled professionals 61
5.3 INDUSTRY TRENDS 62
5.3.1 MINIMALLY INVASIVE PROCEDURES 62
5.3.2 TECHNOLOGICAL ADVANCEMENTS IN DEVICE DESIGN 62
5.3.3 AI AND MACHINE LEARNING INTEGRATION 62
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESSES 62
5.5 PRICING ANALYSIS 63
5.5.1 AVERAGE SELLING PRICE TREND, BY REGION 64
5.5.2 AVERAGE SELLING PRICE, BY KEY PLAYER 65
5.6 VALUE CHAIN ANALYSIS 65
5.7 SUPPLY CHAIN ANALYSIS 66
5.8 ECOSYSTEM ANALYSIS 67
5.9 INVESTMENT AND FUNDING SCENARIO 70
5.10 TECHNOLOGY ANALYSIS 71
5.10.1 KEY TECHNOLOGIES 71
5.10.1.1 Transcatheter aortic valve replacement 71
5.10.1.2 Transcatheter mitral aortic valve replacement 71
5.10.2 COMPLEMENTARY TECHNOLOGIES 72
5.10.2.1 3D printing 72
5.11 PATENT ANALYSIS 72
5.12 TRADE ANALYSIS 74
5.12.1 HS CODES 74
5.12.2 EXPORT DATA 75
5.12.3 IMPORT DATA 76
5.13 KEY CONFERENCES AND EVENTS, 2024-2025 77
5.14 CASE STUDY ANALYSIS 78
5.14.1 SAPIEN 3 TRANSCATHETER HEART VALVE FOR PRECISION PLACEMENT 78
5.14.2 MITRACLIP TRANSCATHETER EDGE-TO-EDGE REPAIR TO REDUCE HOSPITALIZATION 78
5.14.3 WATCHMAN FLX DEVICE FOR LEFT ATRIAL APPENDAGE 78
5.15 REGULATORY LANDSCAPE 79
5.15.1 REGULATORY ANALYSIS 79
5.15.1.1 North America 79
5.15.1.1.1 US 79
5.15.1.1.2 Canada 79
5.15.1.2 Europe 80
5.15.1.3 Asia Pacific 80
5.15.1.3.1 Japan 80
5.15.1.3.2 China 80
5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
5.16 PORTER'S FIVE FORCE ANALYSIS 83
5.16.1 THREAT OF NEW ENTRANTS 85
5.16.2 THREAT OF SUBSTITUTES 85
5.16.3 BARGAINING POWER OF SUPPLIERS 85
5.16.4 BARGAINING POWER OF BUYERS 85
5.16.5 INTENSITY OF COMPETITIVE RIVALRY 85
5.17 KEY STAKEHOLDERS AND BUYING CRITERIA 86
5.17.1 KEY STAKEHOLDERS 86
5.17.2 BUYING CRITERIA 87
5.18 REIMBURSEMENT ANALYSIS 87
5.19 UNMET NEEDS AND END-USER EXPECTATIONS 89
5.19.1 UNMET NEEDS 89
5.19.2 END-USER EXPECTATIONS 89
5.20 IMPACT OF AI/GEN AI ON STRUCTURAL HEART DEVICES MARKET 90
5.20.1 INTRODUCTION 90
5.20.2 KEY COMPANIES IMPLEMENTING AI 90
5.20.3 MARKET POTENTIAL OF AI IN STRUCTURAL HEART DEVICES MARKET 90
6 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE 91
6.1 INTRODUCTION 92
6.2 REPLACEMENT PROCEDURES 92
6.2.1 TAVR/TAVI REPLACEMENT PROCEDURES 93
6.2.1.1 Quicker recuperation and shorter hospital stays to promote growth 93
6.2.2 SAVR PROCEDURES 95
6.2.2.1 Wide adoption for treating valvular heart diseases to sustain growth 95
6.3 REPAIR PROCEDURES 96
6.3.1 CLOSURE PROCEDURES 97
6.3.1.1 Increasing prevalence of structural heart defects to boost market 97
6.3.2 ANNULOPLASTY 99
6.3.2.1 Growing focus on safety and efficacy to drive market 99
6.3.3 VALVULOPLASTY 100
6.3.3.1 Increasing cases of aortic stenosis and valvular regurgitation to fuel market 100
6.3.4 TMVR PROCEDURES 102
6.3.4.1 Growing preference over valve replacement to promote growth 102
6.3.5 TEER PROCEDURES 104
6.3.5.1 Global prevalence of mitral regurgitation to expedite growth 104
7 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT 105
7.1 INTRODUCTION 106
7.2 HEART VALVE DEVICES 107
7.2.1 TRANSCATHETER HEART VALVES 108
7.2.1.1 Transcatheter mitral valve replacement 110
7.2.1.1.1 Growing use in treating age-related degeneration and heart diseases to boost market 110
7.2.1.2 Transcatheter aortic valve replacement 112
7.2.1.2.1 Increasing instances of aortic valve replacement to aid growth 112
7.2.2 SURGICAL VALVES 114
7.2.2.1 Mechanical valves 115
7.2.2.1.1 Higher durability and affordability to encourage growth 115
7.2.2.2 Biological valves 116
7.2.2.2.1 Need for reduced incidence of bleeding to accelerate growth 116
7.3 OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS 118
7.4 ANNULOPLASTY RINGS 119
7.4.1 HIGH PREVALENCE OF MITRAL AND TRICUSPID VALVE REGURGITATION DISEASES TO PROMOTE GROWTH 119
7.5 ACCESSORIES 121
7.5.1 CATHETERS 122
7.5.1.1 Growing preference for minimally invasive procedures to fuel market 122
7.5.2 GUIDEWIRES 124
7.5.2.1 Need for precise navigation and placement of medical devices to augment growth 124
7.5.3 SHEATHS 125
7.5.3.1 Need for minimizing vascular trauma to promote growth 125
7.5.4 OTHER ACCESSORIES 127
?
8 STRUCTURAL HEART DEVICES MARKET, BY END USER 128
8.1 INTRODUCTION 129
8.1.1 HOSPITALS 129
8.1.1.1 Ability to handle large volume of patients to boost market 129
8.1.2 AMBULATORY SURGICAL CENTRES 130
8.1.2.1 Faster procedure time and lower infection rates to drive market 130
8.1.3 OTHER END USERS 132
9 STRUCTURAL HEART DEVICES MARKET, BY REGION 133
9.1 INTRODUCTION 134
9.2 NORTH AMERICA 134
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 135
9.2.2 US 139
9.2.2.1 Favorable reimbursement scenario to augment growth 139
9.2.3 CANADA 143
9.2.3.1 Rising prevalence of target diseases to drive market 143
9.3 EUROPE 147
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 147
9.3.2 GERMANY 151
9.3.2.1 Increase in geriatric and obese population to stimulate growth 151
9.3.3 UK 155
9.3.3.1 Increasing incidence of peripheral vascular diseases to support growth 155
9.3.4 FRANCE 159
9.3.4.1 Favorable government initiatives to drive market 159
9.3.5 ITALY 163
9.3.5.1 Increasing health expenditure and rising diabetes prevalence to boost market 163
9.3.6 SPAIN 166
9.3.6.1 Growing geriatric population to propel market 166
9.3.7 REST OF EUROPE 170
9.4 ASIA PACIFIC 175
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 175
9.4.2 JAPAN 180
9.4.2.1 Increasing healthcare expenditure to boost market 180
9.4.3 CHINA 184
9.4.3.1 Growing target patient population to drive market 184
9.4.4 INDIA 188
9.4.4.1 Increasing prevalence of diabetes to expedite growth 188
9.4.5 AUSTRALIA 191
9.4.5.1 Growing hospitalizations due to coronary artery diseases to fuel market 191
?
9.4.6 SOUTH KOREA 196
9.4.6.1 Increasing prevalence of hypertension to support growth 196
9.4.7 REST OF ASIA PACIFIC 200
9.5 LATIN AMERICA 203
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 203
9.5.2 BRAZIL 207
9.5.2.1 Rising healthcare expenditure to aid growth 207
9.5.3 MEXICO 211
9.5.3.1 Increasing prevalence of cardiovascular diseases to spur growth 211
9.5.4 REST OF LATIN AMERICA 215
9.6 MIDDLE EAST & AFRICA 218
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 218
9.6.2 GCC COUNTRIES 222
9.6.2.1 Rising cases of hypertension and associated cardiovascular diseases to drive market 222
9.6.3 REST OF MIDDLE EAST & AFRICA 225
10 COMPETITIVE LANDSCAPE 229
10.1 INTRODUCTION 229
10.2 KEY PLAYER STRATEGY/RIGHT TO WIN 229
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS 229
10.3 REVENUE ANALYSIS, 2019-2023 230
10.4 MARKET SHARE ANALYSIS, 2023 231
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 232
10.5.1 STARS 232
10.5.2 EMERGING LEADERS 232
10.5.3 PERVASIVE PLAYERS 233
10.5.4 PARTICIPANTS 233
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 234
10.5.5.1 Company footprint 234
10.5.5.2 Product footprint 235
10.5.5.3 Procedure footprint 236
10.5.5.4 End-user footprint 237
10.5.5.5 Region footprint 238
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 239
10.6.1 PROGRESSIVE COMPANIES 239
10.6.2 DYNAMIC COMPANIES 239
10.6.3 RESPONSIVE COMPANIES 239
10.6.4 STARTING BLOCKS 239
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 241
10.7 BRAND/PRODUCT COMPARISON 242
?
10.8 COMPANY VALUATION AND FINANCIAL METRICS 242
10.8.1 FINANCIAL METRICS 242
10.8.2 COMPANY VALUATION 243
10.9 COMPETITIVE SCENARIO 243
10.9.1 PRODUCT LAUNCHES AND APPROVALS 243
10.9.2 DEALS 245
11 COMPANY PROFILES 246
11.1 KEY PLAYERS 246
11.1.1 EDWARDS LIFESCIENCES CORPORATION 246
11.1.1.1 Business overview 246
11.1.1.2 Products offered 247
11.1.1.3 Recent developments 248
11.1.1.3.1 Deals 248
11.1.1.4 MnM view 249
11.1.1.4.1 Right to win 249
11.1.1.4.2 Strategic choices 249
11.1.1.4.3 Weaknesses and competitive threats 249
11.1.2 MEDTRONIC 250
11.1.2.1 Business overview 250
11.1.2.2 Products offered 252
11.1.2.3 Recent developments 252
11.1.2.3.1 Product launches and approvals 252
11.1.2.3.2 Deals 253
11.1.2.4 MnM view 253
11.1.2.4.1 Right to win 253
11.1.2.4.2 Strategic choices 253
11.1.2.4.3 Weaknesses and competitive threats 253
11.1.3 ABBOTT 254
11.1.3.1 Business overview 254
11.1.3.2 Products offered 255
11.1.3.3 Recent developments 256
11.1.3.3.1 Product launches and approvals 256
11.1.3.3.2 Deals 257
11.1.3.4 MnM view 257
11.1.3.4.1 Right to win 257
11.1.3.4.2 Strategic choices 257
11.1.3.4.3 Weaknesses and competitive threats 257
11.1.4 BOSTON SCIENTIFIC CORPORATION 258
11.1.4.1 Business overview 258
11.1.4.2 Products offered 259
11.1.4.3 Recent developments 260
11.1.4.3.1 Product launches and approvals 260
11.1.5 TELEFLEX 261
11.1.5.1 Business overview 261
11.1.5.2 Products offered 262
11.1.5.3 Recent developments 263
11.1.5.3.1 Product launches and approvals 263
11.1.5.3.2 Deals 263
11.1.6 INTEGER HOLDINGS CORPORATION 264
11.1.6.1 Business overview 264
11.1.6.2 Products offered 265
11.1.6.3 Recent developments 266
11.1.6.3.1 Deals 266
11.1.6.3.2 Expansions 266
11.1.7 LEPU MEDICAL TECHNOLOGY CO., LTD. 267
11.1.7.1 Business overview 267
11.1.7.2 Products offered 268
11.1.7.3 Recent developments 270
11.1.7.3.1 Product launches and approvals 270
11.1.8 TTK HEALTHCARE 271
11.1.8.1 Business overview 271
11.1.8.2 Products offered 272
11.1.9 ARTIVION, INC. 273
11.1.9.1 Business overview 273
11.1.9.2 Products offered 274
11.1.10 VENUS MEDTECH (HANGZHOU) INC. 276
11.1.10.1 Business overview 276
11.1.10.2 Products offered 277
11.1.10.3 Recent developments 277
11.1.10.3.1 Product launches and approvals 277
11.1.11 LIFETECH SCIENTIFIC CORPORATION 278
11.1.11.1 Business overview 278
11.1.11.2 Products offered 279
11.1.12 COOK 281
11.1.12.1 Business overview 281
11.1.12.2 Products offered 281
11.1.12.3 Recent developments 282
11.1.12.3.1 Deals 282
11.1.13 CORDIS 283
11.1.13.1 Business overview 283
11.1.13.2 Products offered 283
11.1.13.3 Recent developments 284
11.1.13.3.1 Product launches and approvals 284
11.1.14 SMT 285
11.1.14.1 Business overview 285
11.1.14.2 Products offered 285
11.1.14.3 Recent developments 286
11.1.14.3.1 Other developments 286
11.1.15 MERIL LIFE SCIENCES PVT. LTD. 287
11.1.15.1 Business overview 287
11.1.15.2 Products offered 288
11.1.16 W. L. GORE & ASSOCIATES, INC. 289
11.1.16.1 Business overview 289
11.1.16.2 Products offered 289
11.2 OTHER PLAYERS 291
11.2.1 FOLDAX 291
11.2.2 MICRO INTERVENTIONAL DEVICES, INCORPORATED 292
11.2.3 CARDIAC DIMENSIONS 292
11.2.4 BIOTRONIK 293
11.2.5 HIGHLIFE MEDICAL 294
11.2.6 MITRALIGN 294
11.2.7 BRAILE BIOMEDICA 295
11.2.8 JENAVALVE 295
11.2.9 CORCYM 296
11.2.10 XELTIS 296
11.2.11 INNOVHEART SRL 297
12 APPENDIX 298
12.1 DISCUSSION GUIDE 298
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL 301
12.3 CUSTOMIZATION OPTIONS 303
12.4 RELATED REPORTS 303
12.5 AUTHOR DETAILS 304

TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2020-2023 32
TABLE 2 STRUCTURAL HEART DEVICES MARKET: RESEARCH ASSUMPTIONS 45
TABLE 3 STRUCTURAL HEART DEVICES MARKET: RISK ASSESSMENT 45
TABLE 4 GERIATRIC POPULATION, BY REGION, 2030 56
TABLE 5 NATIONAL AVERAGE REIMBURSEMENT RATES FOR NORTH AMERICA AND EUROPE, 2024-2025 58
TABLE 6 STRUCTURAL HEART DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 68
TABLE 7 STRUCTURAL HEART DEVICES MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2021-2023 72
TABLE 8 HS CODES FOR STRUCTURAL HEART DEVICES MARKET 74
TABLE 9 EXPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023 75
TABLE 10 IMPORT DATA FOR STRUCTURAL HEART DEVICES, BY COUNTRY, 2023 76
TABLE 11 STRUCTURAL HEART DEVICES MARKET: KEY CONFERENCES AND EVENTS,
2024-2025 77
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 81
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81
TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82
TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 83
TABLE 17 STRUCTURAL HEART DEVICES MARKET: PORTER'S FIVE FORCES ANALYSIS 84
TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT 86
TABLE 19 KEY BUYING CRITERIA FOR STRUCTURAL HEART DEVICES MARKET, BY PRODUCT 87
TABLE 20 CPT CODES FOR STRUCTURAL HEART DEVICES MARKET 88
TABLE 21 STRUCTURAL HEART DEVICES MARKET: UNMET NEEDS 89
TABLE 22 STRUCTURAL HEART DEVICES MARKET: END-USER EXPECTATIONS 89
TABLE 23 STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 92
TABLE 24 STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 92
TABLE 25 STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,
BY COUNTRY, 2022-2029 (USD MILLION) 93
TABLE 26 STRUCTURAL HEART DEVICES MARKET FOR TAVR/TAVI PROCEDURES,
BY COUNTRY, 2022-2029 (USD MILLION) 94
TABLE 27 STRUCTURAL HEART DEVICES MARKET FOR SAVR PROCEDURES,
BY COUNTRY, 2022-2029 (USD MILLION) 95
TABLE 28 STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 96
TABLE 29 STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY COUNTRY, 2022-2029 (USD MILLION) 97
TABLE 30 STRUCTURAL HEART DEVICES MARKET FOR CLOSURE PROCEDURES,
BY COUNTRY, 2022-2029 (USD MILLION) 98
TABLE 31 STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY, BY COUNTRY,
2022-2029 (USD MILLION) 100
TABLE 32 STRUCTURAL HEART DEVICES MARKET FOR VALVULOPLASTY, BY COUNTRY, 2022-2029 (USD MILLION) 101
TABLE 33 STRUCTURAL HEART DEVICES MARKET FOR TMVR PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION) 103
TABLE 34 STRUCTURAL HEART DEVICES MARKET FOR TEER PROCEDURES, BY COUNTRY, 2022-2029 (USD MILLION) 104
TABLE 35 STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 106
TABLE 36 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES,
BY REGION, 2022-2029 (THOUSAND UNITS) 106
TABLE 37 STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY REGION, 2022-2029 (THOUSAND UNITS) 107
TABLE 38 STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY COUNTRY, 2022-2029 (USD MILLION) 108
TABLE 39 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES,
BY COUNTRY, 2022-2029 (USD MILLION) 109
TABLE 40 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER MITRAL VALVE REPLACEMENT, BY COUNTRY, 2022-2029 (USD MILLION) 111
TABLE 41 STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT, BY COUNTRY, 2022-2029 (USD MILLION) 113
TABLE 42 STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY COUNTRY, 2022-2029 (USD MILLION) 114
TABLE 43 STRUCTURAL HEART DEVICES MARKET FOR MECHANICAL VALVES, BY COUNTRY, 2022-2029 (USD MILLION) 116
TABLE 44 STRUCTURAL HEART DEVICES MARKET FOR BIOLOGICAL VALVES, BY COUNTRY, 2022-2029 (USD MILLION) 117
TABLE 45 STRUCTURAL HEART DEVICES MARKET FOR OCCLUDERS, CLOSURE SYSTEMS, AND DELIVERY SYSTEMS, BY COUNTRY, 2022-2029 (USD MILLION) 118
TABLE 46 STRUCTURAL HEART DEVICES MARKET FOR ANNULOPLASTY RINGS, BY COUNTRY, 2022-2029 (USD MILLION) 120
TABLE 47 STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,
2022-2029 (USD MILLION) 121
TABLE 48 STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY COUNTRY,
2022-2029 (USD MILLION) 122
TABLE 49 STRUCTURAL HEART DEVICES MARKET FOR CATHETERS, BY COUNTRY,
2022-2029 (USD MILLION) 123
TABLE 50 STRUCTURAL HEART DEVICES MARKET FOR GUIDEWIRES, BY COUNTRY,
2022-2029 (USD MILLION) 125
TABLE 51 STRUCTURAL HEART DEVICES MARKET FOR SHEATHS, BY COUNTRY,
2022-2029 (USD MILLION) 126
TABLE 52 STRUCTURAL HEART DEVICES MARKET FOR OTHER ACCESSORIES, BY COUNTRY, 2022-2029 (USD MILLION) 127
TABLE 53 STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 129
TABLE 54 STRUCTURAL HEART DEVICES MARKET FOR HOSPITALS, BY REGION,
2022-2029 (USD MILLION) 130
TABLE 55 STRUCTURAL HEART DEVICES MARKET FOR AMBULATORY SURGICAL CENTRES,
BY REGION, 2022-2029 (USD MILLION) 131
TABLE 56 STRUCTURAL HEART DEVICES MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION) 132
TABLE 57 STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 134
TABLE 58 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 136
TABLE 59 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 136
TABLE 60 NORTH AMERICA: HEART VALVE DEVICES MARKET, BY TYPE,
2022-2029 (USD MILLION) 136
TABLE 61 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 137
TABLE 62 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 137
TABLE 63 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 138
TABLE 64 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 138
TABLE 65 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 138
TABLE 66 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 139
TABLE 67 NORTH AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 139
TABLE 68 US: KEY MACROECONOMIC INDICATORS 140
TABLE 69 US: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 140
TABLE 70 US: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 140
TABLE 71 US: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 141
TABLE 72 US: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 141
TABLE 73 US: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,
2022-2029 (USD MILLION) 142
TABLE 74 US: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 142
TABLE 75 US: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 142
TABLE 76 US: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 143
TABLE 77 US: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 143
TABLE 78 CANADA: KEY MACROECONOMIC INDICATORS 144
TABLE 79 CANADA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 144
TABLE 80 CANADA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 144
TABLE 81 CANADA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 82 CANADA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 83 CANADA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 145
TABLE 84 CANADA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 146
TABLE 85 CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 86 CANADA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 146
TABLE 87 CANADA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 147
TABLE 88 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 148
TABLE 89 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 148
TABLE 90 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 148
TABLE 91 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 92 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 93 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 149
TABLE 94 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 150
TABLE 95 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 96 EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 150
TABLE 97 EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 151
TABLE 98 GERMANY: KEY MACROECONOMIC INDICATORS 151
TABLE 99 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022- 2029 (USD MILLION) 152
TABLE 100 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 152
TABLE 101 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 152
TABLE 102 GERMANY: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 153
TABLE 103 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 153
TABLE 104 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 153
TABLE 105 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 154
TABLE 106 GERMANY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 154
TABLE 107 GERMANY: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 154
TABLE 108 UK: KEY MACROECONOMIC INDICATORS 155
TABLE 109 UK: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 156
TABLE 110 UK: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 111 UK: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 156
TABLE 112 UK: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 157
TABLE 113 UK: STRUCTURAL HEART DEVICES FOR ACCESSORIES, BY TYPE,
2022-2029 (USD MILLION) 157
TABLE 114 UK: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 157
TABLE 115 UK: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 116 UK: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 158
TABLE 117 UK: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 158
TABLE 118 FRANCE: KEY MACROECONOMIC INDICATORS 159
TABLE 119 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 160
TABLE 120 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 160
TABLE 121 FRANCE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 160
TABLE 122 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 161
TABLE 123 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION) 161
TABLE 124 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 161
TABLE 125 FRANCE: STRUCTURAL HEART DEVICES FOR REPLACEMENT PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 162
TABLE 126 FRANCE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 162
TABLE 127 FRANCE: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 162
TABLE 128 ITALY: KEY MACROECONOMIC INDICATORS 163
TABLE 129 ITALY: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 163
TABLE 130 ITALY: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 131 ITALY: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 132 ITALY: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 164
TABLE 133 ITALY: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,
2022-2029 (USD MILLION) 165
TABLE 134 ITALY: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 165
TABLE 135 ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 165
TABLE 136 ITALY: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 166
TABLE 137 ITALY: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 166
TABLE 138 SPAIN: KEY MACROECONOMIC INDICATORS 167
TABLE 139 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 167
TABLE 140 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 141 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 142 SPAIN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 168
TABLE 143 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 144 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 169
TABLE 145 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 169
TABLE 146 SPAIN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 170
TABLE 147 SPAIN: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 170
TABLE 148 REST OF EUROPE: PERCENTAGE OF GERIATRIC POPULATION TO TOTAL POPULATION, BY COUNTRY, 2030 (MILLION) 171
TABLE 149 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 171
TABLE 150 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 151 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 152 REST OF EUROPE: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 172
TABLE 153 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 154 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 173
TABLE 155 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 173
TABLE 156 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 174
TABLE 157 REST OF EUROPE: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 174
TABLE 158 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 177
TABLE 159 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 177
TABLE 160 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 177
TABLE 161 ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 162 ASIA PACIFIC: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 163 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 178
TABLE 164 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 179
TABLE 165 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 166 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 179
TABLE 167 ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 180
TABLE 168 JAPAN: KEY MACROECONOMIC INDICATORS 181
TABLE 169 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 181
TABLE 170 JAPAN: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 181
TABLE 171 JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 172 JAPAN: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 173 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 182
TABLE 174 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 183
TABLE 175 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 176 JAPAN: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 183
TABLE 177 JAPAN: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 184
TABLE 178 CHINA: KEY MACROECONOMIC INDICATORS 184
TABLE 179 CHINA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 185
TABLE 180 CHINA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 181 CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 185
TABLE 182 CHINA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 183 CHINA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 186
TABLE 184 CHINA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 186
TABLE 185 CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 186 CHINA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 187
TABLE 187 CHINA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 187
TABLE 188 INDIA: KEY MACROECONOMIC INDICATORS 188
TABLE 189 INDIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 188
TABLE 190 INDIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 191 INDIA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 192 INDIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 189
TABLE 193 INDIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE,
2022-2029 (USD MILLION) 190
TABLE 194 INDIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 190
TABLE 195 INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 190
TABLE 196 INDIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 191
TABLE 197 INDIA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 191
TABLE 198 AUSTRALIA: KEY MACROECONOMIC INDICATORS 192
TABLE 199 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 192
TABLE 200 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 201 AUSTRALIA: STRUCTURAL HEART VALVE DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 202 AUSTRALIA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 193
TABLE 203 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 204 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 194
TABLE 205 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 194
TABLE 206 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 195
TABLE 207 AUSTRALIA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 195
TABLE 208 SOUTH KOREA: KEY MACROECONOMIC INDICATORS 196
TABLE 209 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 197
TABLE 210 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 211 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 197
TABLE 212 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 213 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 198
TABLE 214 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 198
TABLE 215 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 216 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 199
TABLE 217 SOUTH KOREA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 199
TABLE 218 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 200
TABLE 219 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 200
TABLE 220 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 221 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 222 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION) 201
TABLE 223 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES, BY PROCEDURE,
2022-2029 (USD MILLION) 202
TABLE 224 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 225 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 202
TABLE 226 REST OF ASIA PACIFIC: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 203
TABLE 227 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY COUNTRY,
2022-2029 (USD MILLION) 204
TABLE 228 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 204
TABLE 229 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 204
TABLE 230 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 231 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 232 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 205
TABLE 233 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 206
TABLE 234 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 235 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 206
TABLE 236 LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 207
TABLE 237 BRAZIL: KEY MACROECONOMIC INDICATORS 207
TABLE 238 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 208
TABLE 239 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 208
TABLE 240 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 241 BRAZIL: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES,
BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 242 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 209
TABLE 243 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 210
TABLE 244 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 210
TABLE 245 BRAZIL: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 210
TABLE 246 BRAZIL: STRUCTURAL HEART DEVICES MARKET, BY END USER,
2022-2029 (USD MILLION) 211
TABLE 247 MEXICO: KEY MACROECONOMIC INDICATORS 211
TABLE 248 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 212
TABLE 249 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES,
BY TYPE, 2022-2029 (USD MILLION) 212
TABLE 250 MEXICO: STRUCTURAL HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022-2029 (USD MILLION) 212
TABLE 251 MEXICO: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 252 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES,
BY TYPE, 2022-2029 (USD MILLION) 213
TABLE 253 MEXICO: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 213
TABLE 254 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 255 MEXICO: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES,
BY TYPE, 2022-2029 (USD MILLION) 214
TABLE 256 MEXICO: STRUCTURAL HEART DEVICES, MARKET, BY END USER,
2022-2029 (USD MILLION) 214
TABLE 257 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 215
TABLE 258 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 215
TABLE 259 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 260 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 261 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION) 216
TABLE 262 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE, 2022-2029 (USD MILLION) 217
TABLE 263 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 264 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 217
TABLE 265 REST OF LATIN AMERICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 218

TABLE 266 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY REGION, 2022-2029 (USD MILLION) 219
TABLE 267 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT, 2022-2029 (USD MILLION) 219
TABLE 268 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 219
TABLE 269 MIDDLE EAST & AFRICA: HEART VALVES DEVICES FOR TRANSCATHETER HEART VALVES, 2022-2029 (USD MILLION) 220
TABLE 270 MIDDLE EAST & AFRICA: STRUCTURAL HEART VALVES DEVICES MARKET FOR SURGICAL VALVES, BY TYPE, 2022-2029 (USD MILLION) 220
TABLE 271 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION) 220
TABLE 272 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES, BY PROCEDURE,
2022-2029 (USD MILLION) 221
TABLE 273 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 274 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 221
TABLE 275 MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022-2029 (USD MILLION) 222
TABLE 276 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PRODUCT,
2022-2029 (USD MILLION) 222
TABLE 277 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 278 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 279 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 223
TABLE 280 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY ACCESSORIES, 2022-2029 (USD MILLION) 224
TABLE 281 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET, BY PROCEDURE,
2022-2029 (USD MILLION) 224
TABLE 282 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 224
TABLE 283 GCC COUNTRIES: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 225
TABLE 284 GCC COUNTRIES: STRUCTURAL HEART DEVICES, BY END USER,
2022-2029 (USD MILLION) 225
TABLE 285 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,
BY PRODUCT, 2022-2029 (USD MILLION) 226
TABLE 286 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR HEART VALVE DEVICES, BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 287 REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR TRANSCATHETER HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 226
TABLE 288 REST OF MIDDLE EAST & AFRICA: HEART VALVES DEVICES MARKET FOR SURGICAL HEART VALVES, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 289 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR ACCESSORIES, BY TYPE, 2022-2029 (USD MILLION) 227
TABLE 290 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,
BY PROCEDURE, 2022-2029 (USD MILLION) 227
TABLE 291 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPLACEMENT PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 292 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET FOR REPAIR PROCEDURES, BY TYPE, 2022-2029 (USD MILLION) 228
TABLE 293 REST OF MIDDLE EAST & AFRICA: STRUCTURAL HEART DEVICES MARKET,
BY END USER, 2022-2029 (USD MILLION) 228
TABLE 294 STRUCTURAL HEART DEVICES MARKET: DEGREE OF COMPETITION 231
TABLE 295 STRUCTURAL HEART DEVICES MARKET: PRODUCT FOOTPRINT 235
TABLE 296 STRUCTURAL HEART DEVICES MARKET: PROCEDURE FOOTPRINT 236
TABLE 297 STRUCTURAL HEART DEVICES MARKET: END-USER FOOTPRINT 237
TABLE 298 STRUCTURAL HEART DEVICES MARKET: REGION FOOTPRINT 238
TABLE 299 STRUCTURAL HEART DEVICES MARKET: KEY STARTUPS/SMES 241
TABLE 300 STRUCTURAL HEART DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024 244
TABLE 301 STRUCTURAL HEART DEVICES MARKET: DEALS, JANUARY 2021-OCTOBER 2024 245
TABLE 302 EDWARDS LIFESCIENCES CORPORATION: COMPANY OVERVIEW 246
TABLE 303 EDWARDS LIFESCIENCES CORPORATION: PRODUCTS OFFERED 247
TABLE 304 EDWARDS LIFESCIENCES CORPORATION: DEALS, JANUARY 2021-OCTOBER 2024 248
TABLE 305 MEDTRONIC: COMPANY OVERVIEW 250
TABLE 306 MEDTRONIC: PRODUCTS OFFERED 252
TABLE 307 MEDTRONIC: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-
OCTOBER 2024 252
TABLE 308 MEDTRONIC: DEALS, JANUARY 2021-OCTOBER 2024 253
TABLE 309 ABBOTT: COMPANY OVERVIEW 254
TABLE 310 ABBOTT: PRODUCTS OFFERED 255
TABLE 311 ABBOTT: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024 256
TABLE 312 ABBOTT: DEALS, JANUARY 2021-OCTOBER 2024 257
TABLE 313 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 258
TABLE 314 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 259
TABLE 315 BOSTON SCIENTIFIC CORPORATION: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024 260
TABLE 316 TELEFLEX: COMPANY OVERVIEW 261
TABLE 317 TELEFLEX: PRODUCTS OFFERED 262
TABLE 318 TELEFLEX: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-
OCTOBER 2024 263
TABLE 319 TELEFLEX: DEALS, JANUARY 2021-OCTOBER 2024 263
TABLE 320 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 264
TABLE 321 INTEGER HOLDINGS CORPORATION: PRODUCTS OFFERED 265
TABLE 322 INTEGER HOLDINGS CORPORATION: DEALS, JANUARY 2021-OCTOBER 2024 266
TABLE 323 INTEGER HOLDINGS CORPORATION: EXPANSIONS, JANUARY 2021-
OCTOBER 2024 266
TABLE 324 LEPU MEDICAL CO., LTD.: COMPANY OVERVIEW 267
TABLE 325 LEPU MEDICAL CO., LTD.: PRODUCTS OFFERED 268
TABLE 326 LEPU MEDICAL CO, .LTD.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024 270
TABLE 327 TTK HEALTHCARE: COMPANY OVERVIEW 271
TABLE 328 TTK HEALTHCARE: PRODUCTS OFFERED 272
TABLE 329 ARTIVION, INC.: COMPANY OVERVIEW 273
TABLE 330 ARTIVION, INC.: PRODUCTS OFFERED 274
TABLE 331 VENUS MEDTECH (HANGZHOU) INC.: COMPANY OVERVIEW 276
TABLE 332 VENUS MEDTECH (HANGZHOU) INC.: PRODUCTS OFFERED 277
TABLE 333 VENUS MEDTECH (HANGZHOU) INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024 277
TABLE 334 LIFETECH SCIENTIFIC CORPORATION: COMPANY OVERVIEW 278
TABLE 335 LIFETECH SCIENTIFIC CORPORATION: PRODUCTS OFFERED 279
TABLE 336 COOK: COMPANY OVERVIEW 281
TABLE 337 COOK: PRODUCTS OFFERED 281
TABLE 338 COOK: DEALS, JANUARY 2021-OCTOBER 2024 282
TABLE 339 CORDIS: COMPANY OVERVIEW 283
TABLE 340 CORDIS: PRODUCTS OFFERED 283
TABLE 341 CORDIS: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021-OCTOBER 2024 284
TABLE 342 SMT: COMPANY OVERVIEW 285
TABLE 343 SMT: PRODUCTS OFFERED 285
TABLE 344 SMT: OTHER DEVELOPMENTS, JANUARY 2021-OCTOBER 2024 286
TABLE 345 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 287
TABLE 346 MERIL LIFESCIENCES PVT. LTD.: PRODUCTS OFFERED 288
TABLE 347 W.L. GORE & ASSOCIATES, INC.: COMPANY OVERVIEW 289
TABLE 348 W.L. GORE & ASSOCIATES, INC.: PRODUCTS OFFERED 289
TABLE 349 FOLDAX: COMPANY OVERVIEW 291
TABLE 350 MICRO INTERVENTIONAL DEVICES, INCORPORATED: COMPANY OVERVIEW 292
TABLE 351 CARDIAC DIMENSIONS: COMPANY OVERVIEW 292
TABLE 352 BIOTRONIK: COMPANY OVERVIEW 293
TABLE 353 HIGHLIFE MEDICAL: COMPANY OVERVIEW 294
TABLE 354 MITRALIGN: COMPANY OVERVIEW 294
TABLE 355 BRAILE BIOMEDICA: COMPANY OVERVIEW 295
TABLE 356 JENAVALVE: COMPANY OVERVIEW 295
TABLE 357 CORCYM: COMPANY OVERVIEW 296
TABLE 358 XELTIS: COMPANY OVERVIEW 296
TABLE 359 INNOVHEART SRL: COMPANY OVERVIEW 297